| 3-MCPD | 3-monochloropropane-1,2-diol |
| 4-HHE | 4-hydroxy-2-hexenal |
| 4-HNE | 4-hydroxy-2-nonenal |
| 8-OHdG | 8-hydroxy-2′-deoxyguanosine |
| AD | Alzheimer’s disease |
| AFB1 | Aflatoxin B1 |
| AGEs | Advanced glycation end-products |
| AhR | Aryl hydrocarbon receptor |
| Akt | Protein kinase B |
| AMPK | AMP-activated protein kinase |
| AP-1 | Activator protein 1 |
| ARE | Antioxidant response element |
| ATP | Adenosine triphosphate |
| Aβ | Amyloid beta |
| BaP | Benzo[a]pyrene |
| BHA | Butylated hydroxyanisole |
| BHT | Butylated hydroxytoluene |
| CAT | Catalase |
| CDS | Cognitive dysfunction syndrome |
| CKD | Chronic kidney disease |
| CML | Nε-carboxymethyllysine |
| CNS | Central nervous system |
| CoQ10 | Coenzyme Q10 |
| CRC | Colorectal cancer |
| CYP | Cytochrome P450 |
| DHA | Docosahexaenoic acid |
| DNA | Deoxyribonucleic acid |
| EGCG | Epigallocatechin-3-gallate |
| EPA | Eicosapentaenoic acid |
| ER | Endoplasmic reticulum |
| ETC | Electron transport chain |
| GPx | Glutathione peroxidase |
| GPx4 | Glutathione peroxidase 4 |
| GSH | Reduced glutathione |
| GSSG | Oxidized glutathione |
| GST | Glutathione S-transferase |
| HAT | Hydrogen atom transfer |
| HCAs | Heterocyclic aromatic amines |
| HCC | Hepatocellular carcinoma |
| HO-1 | Heme oxygenase-1 |
| H2O2 | Hydrogen peroxide |
| IARC | International Agency for Research on Cancer |
| IBD | Inflammatory bowel disease |
| IL-6 | Interleukin-6 |
| JNK | c-Jun N-terminal kinase |
| Keap1 | Kelch-like ECH-associated protein 1 |
| LDL | Low-density lipoprotein |
| LOPs | Lipid oxidation products |
| LPS | Lipopolysaccharide |
| MAM | Mitochondria-associated membrane |
| MDA | Malondialdehyde |
| MG-H1 | Methylglyoxal-derived hydroimidazolone 1 |
| MnSOD | Manganese superoxide dismutase |
| mTOR | Mechanistic target of rapamycin |
| NAFLD | Nonalcoholic fatty liver disease |
| NASH | Nonalcoholic steatohepatitis |
| NF-κB | Nuclear factor kappa B |
| NO | Nitric oxide |
| NOCs | N-nitroso compounds |
| Nox/NOX | NADPH oxidase |
| NQO1 | NAD(P)H quinone oxidoreductase 1 |
| Nrf2/NRF2 | Nuclear factor erythroid 2-related factor 2 |
| O2•− | Superoxide anion radical |
| oxLDL | Oxidized low-density lipoprotein |
| •OH | Hydroxyl radical |
| PAHs | Polycyclic aromatic hydrocarbons |
| PD | Parkinson’s disease |
| PGC-1α | Peroxisome proliferator-activated receptor gamma coactivator 1 α |
| PICs | Processing-induced contaminants |
| PUFAs | Polyunsaturated fatty acids |
| RAGE | Receptor for advanced glycation end-products |
| ROO• | Peroxyl radical |
| ROS | Reactive oxygen species |
| SCFA | Short-chain fatty acid |
| SET | Single electron transfer |
| SIRT1 | Sirtuin 1 |
| SOD | Superoxide dismutase |
| SPMs | Specialized pro-resolving mediators |
| T2DM | Type 2 diabetes mellitus |
| TBARS | Thiobarbituric acid-reactive substances |
| TBHQ | tert-butylhydroquinone |
| TNF-α | Tumor necrosis factor α |
| TRX2 | Mitochondrial thioredoxin 2 |
| TrxR | Thioredoxin reductase |
| UPFPs | Ultra-processed food products |
| UPR | Unfolded protein response |
| 1O2 | Singlet oxygen |